Filings under COLL by Collins Industries Inc (CIK 0000021759) from Jan 30, 2006 to Feb 27, 2006 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Santini Gino | Director | Option exercise(M) | 9K | $16.49 | $143K |
| Jun 8, 2026 | Santini Gino | Director | Option exercise(M) | 9K | — | $0 |
| May 18, 2026 | Freund John Gordon | Director | Sell(S) | 20 | $34.05 | $681 |
| May 15, 2026 | Freund John Gordon | Director | Option exercise(M) | 9K | $16.49 | $143K |
| May 15, 2026 | Freund John Gordon | Director | Sell(S) | 4K | $34.54 | $143K |
| May 15, 2026 | Freund John Gordon | Director | Option exercise(M) | 9K | — | $0 |
| May 14, 2026 | Balice-Gordon Rita J. | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Lurker Nancy | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Paya Carlos V | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Glancy Donovan Michael | Director | Grant(A) | 17K | — | $0 |
| May 14, 2026 | Bohlin Garen G | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Santini Gino | Director | Grant(A) | 9K | — | $0 |
| May 14, 2026 | Freund John Gordon | Director | Grant(A) | 9K | — | $0 |
| May 13, 2026 | Lurker Nancy | Director | Sell(S) | 5K | $35.97 | $162K |
| May 11, 2026 | Bohlin Garen G | Director | Option exercise(M) | 9K | $16.49 | $143K |
| May 11, 2026 | Bohlin Garen G | Director | Sell(S) | 9K | $37.18 | $323K |
| May 11, 2026 | Bohlin Garen G | Director | Option exercise(M) | 9K | — | $0 |
| Mar 18, 2026 | Dieter David | EVP & General Counsel | Sell(S) | 14K | $34.92 | $488K |
| Mar 17, 2026 | Dieter David | EVP & General Counsel | Tax withholding(F) | 9K | $35.72 | $316K |
| Mar 9, 2026 | Dieter David | EVP & General Counsel | Sell(S) | 6K | $36.65 | $228K |
| Mar 3, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 4K | $40.99 | $146K |
| Mar 3, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 46K | $40.36 | $1.9M |
| Feb 10, 2026 | Karnani Vikram | President and CEO, Director | Tax withholding(F) | 11K | $46.75 | $528K |
| Feb 10, 2026 | Karnani Vikram | President and CEO, Director | Grant(A) | 33K | — | $0 |
| Feb 10, 2026 | Karnani Vikram | President and CEO, Director | Grant(A) | 79K | — | $0 |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Tax withholding(F) | 22K | $46.75 | $1.0M |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Tax withholding(F) | 10K | $46.75 | $466K |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Grant(A) | 31K | — | $0 |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | Grant(A) | 19K | — | $0 |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | Tax withholding(F) | 6K | $46.75 | $276K |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | Tax withholding(F) | 12K | $46.75 | $539K |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | Grant(A) | 23K | — | $0 |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | Grant(A) | 14K | — | $0 |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | Grant(A) | 33K | — | $0 |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | Grant(A) | 26K | — | $0 |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | Tax withholding(F) | 12K | $46.75 | $555K |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | Tax withholding(F) | 27K | $46.75 | $1.2M |
| Feb 10, 2026 | Dieter David | EVP & General Counsel | Grant(A) | 22K | — | $0 |
| Feb 10, 2026 | Dieter David | EVP & General Counsel | Grant(A) | 9K | — | $0 |
| Feb 10, 2026 | Dieter David | EVP & General Counsel | Tax withholding(F) | 3K | $46.75 | $130K |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 11K | $47.89 | $533K |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 6K | $48.66 | $315K |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Option exercise(M) | 18K | $15.90 | $280K |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Option exercise(M) | 18K | — | $0 |
| Dec 5, 2025 | Balice-Gordon Rita J. | Director | Sell(S) | 4K | $47.03 | $172K |
| Nov 12, 2025 | Fallon John A. | Director | Option exercise(M) | 15K | $16.49 | $247K |
| Nov 12, 2025 | Fallon John A. | Director | Sell(S) | 35K | $47.21 | $1.6M |
| Nov 12, 2025 | Fallon John A. | Director | Option exercise(M) | 20K | $9.33 | $185K |
| Nov 12, 2025 | Fallon John A. | Director | Option exercise(M) | 20K | — | $0 |
| Nov 12, 2025 | Fallon John A. | Director | Option exercise(M) | 15K | — | $0 |
| Nov 12, 2025 | Karnani Vikram | President and CEO, Director | Tax withholding(F) | 9K | $47.35 | $425K |
| Nov 6, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 25K | $40.38 | $1.0M |
| Nov 6, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 5K | $41.28 | $201K |
| Aug 29, 2025 | Smith Thomas B | EVP and Chief Medical Officer | Sell(S) | 17K | $38.42 | $672K |
| Aug 18, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Option exercise(M) | 16K | $21.34 | $350K |
| Aug 18, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 16K | $38.21 | $626K |
| Aug 18, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Option exercise(M) | 16K | — | $0 |
| Aug 15, 2025 | Santini Gino | Director | Option exercise(M) | 15K | $13.45 | $202K |
| Aug 15, 2025 | Santini Gino | Director | Sell(S) | 5K | $37.19 | $201K |
| Aug 15, 2025 | Santini Gino | Director | Option exercise(M) | 15K | — | $0 |
| Aug 13, 2025 | Rubric Capital Management LP | 10% Owner | Sell(S) | 25K | $37.85 | $946K |
| Aug 13, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Option exercise(M) | 5K | $21.34 | $104K |
| Aug 13, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 5K | $38.03 | $185K |
| Aug 13, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Option exercise(M) | 5K | — | $0 |
| Aug 8, 2025 | Freund John Gordon | Director | Sell(S) | 12K | $34.36 | $401K |
| Jun 9, 2025 | Freund John Gordon | Director | Option exercise(M) | 15K | $13.45 | $202K |
| Jun 9, 2025 | Freund John Gordon | Director | Sell(S) | 7K | $30.62 | $202K |
| Jun 9, 2025 | Freund John Gordon | Director | Option exercise(M) | 15K | — | $0 |
| May 15, 2025 | Paya Carlos V | Director | Grant(A) | 20K | — | $0 |
| May 15, 2025 | Santini Gino | Director | Grant(A) | 10K | — | $0 |
| May 15, 2025 | Freund John Gordon | Director | Grant(A) | 10K | — | $0 |
| May 15, 2025 | Balice-Gordon Rita J. | Director | Grant(A) | 10K | — | $0 |
| May 15, 2025 | Bohlin Garen G | Director | Grant(A) | 10K | — | $0 |
| May 15, 2025 | Lurker Nancy | Director | Grant(A) | 10K | — | $0 |
| May 15, 2025 | Fallon John A. | Director | Grant(A) | 10K | — | $0 |
| Mar 21, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 19K | $30.03 | $567K |
| Mar 21, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 6K | $30.03 | $192K |
| Mar 20, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 2K | $30.00 | $58K |
| Mar 20, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 1K | $30.00 | $36K |
| Mar 17, 2025 | Dieter David | EVP & General Counsel | Grant(A) | 68K | — | $0 |
| Mar 14, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 2K | $30.00 | $68K |
| Mar 14, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 977 | $30.00 | $29K |
| Mar 11, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 10K | $30.01 | $313K |
| Mar 11, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 15K | $30.00 | $462K |
| Mar 7, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 2K | $30.00 | $70K |
| Mar 7, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 2K | $30.00 | $45K |
| Mar 6, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Sell(S) | 26K | $28.50 | $743K |
| Mar 6, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell(S) | 3K | $30.00 | $99K |
| Mar 6, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell(S) | 2K | $30.00 | $58K |
| Mar 5, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Sell(S) | 20K | $28.03 | $561K |
| Mar 4, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Sell(S) | 40K | $28.08 | $1.1M |
| Mar 4, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Option exercise(M) | 40K | $24.03 | $961K |
| Mar 4, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Option exercise(M) | 40K | — | $0 |
| Feb 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Tax withholding(F) | 10K | $30.52 | $300K |
| Feb 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Tax withholding(F) | 25K | $30.52 | $768K |
| Feb 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Grant(A) | 29K | — | $0 |
| Feb 10, 2025 | Kuhlmann Shirley R. | EVP and General Counsel | Grant(A) | 41K | — | $0 |
| Feb 10, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Grant(A) | 27K | — | $0 |
| Feb 10, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Grant(A) | 52K | — | $0 |
| Feb 10, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Tax withholding(F) | 22K | $30.52 | $681K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Collegium Pharmaceutical, Inc, SEC CIK 0001267565. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under COLL and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for COLL